SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-20-136001
Filing Date
2020-05-07
Accepted
2020-05-07 13:42:06
Documents
30
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 10-K d792786d10k.htm   iXBRL 10-K 866943
2 EX-31.1 d792786dex311.htm EX-31.1 3230
3 EX-31.2 d792786dex312.htm EX-31.2 3275
4 EX-32.1 d792786dex321.htm EX-32.1 3330
5 EX-32.2 d792786dex322.htm EX-32.2 3375
11 GRAPHIC g792786g85i86.jpg GRAPHIC 18356
  Complete submission text file 0001193125-20-136001.txt   1617973

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA ck0001792044-20191231.xsd EX-101.SCH 10146
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ck0001792044-20191231_cal.xml EX-101.CAL 14746
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ck0001792044-20191231_def.xml EX-101.DEF 31042
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE ck0001792044-20191231_lab.xml EX-101.LAB 79492
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ck0001792044-20191231_pre.xml EX-101.PRE 67537
20 EXTRACTED XBRL INSTANCE DOCUMENT d792786d10k_htm.xml XML 36281
Mailing Address 235 EAST 42ND STREET NEW YORK NY 10017
Business Address 235 EAST 42ND STREET NEW YORK NY 10017 (212) 733-2323
Upjohn Inc (Filer) CIK: 0001792044 (see all company filings)

IRS No.: 834364296 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-56114 | Film No.: 20855636
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences